At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 25 enrolled
Drug / intervention
Pregabalin (Lyrica) +1 moredrug
Likely dose
Pregabalin (Lyrica) 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Effect Of Pregabalin In Post-Traumatic Neuropathic Pain Patients
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted Apr 9, 2008·Updated Feb 9, 2021
In Brief
A Phase 1 clinical trial evaluating Pregabalin (Lyrica) and Placebo for Nerve Pain. Completed, enrolled 25 participants across 5 sites in 2 countries.
Detailed Summary
The purpose of this study is to assess whether a cross-over type study design in post-traumatic neuropathic patients can be used to assess the activity of potential analgesic agents
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNerve Pain
CountriesCanada, Sweden
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 2008
Enrollment StartMay 2008
Primary CompletionFeb 2009
TodayJul 2026
First PostedApr 9, 2008
Enrollment StartMay 1, 2008
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 18.2 years ago
Interventions
Pregabalin (Lyrica)drug
Oral, 75mg or 150mg capsules, BID
Placebodrug
Oral, matched capsules, BID